Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

WOOF vs IDXX vs ZTS vs CHWY

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
WOOF
Petco Health and Wellness Company, Inc.

Specialty Retail

Consumer CyclicalNASDAQ • US
Market Cap$752M
5Y Perf.-89.4%
IDXX
IDEXX Laboratories, Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$45.45B
5Y Perf.+19.5%
ZTS
Zoetis Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • US
Market Cap$36.86B
5Y Perf.-43.4%
CHWY
Chewy, Inc.

Specialty Retail

Consumer CyclicalNYSE • US
Market Cap$9.80B
5Y Perf.-76.8%

WOOF vs IDXX vs ZTS vs CHWY — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
WOOF logoWOOF
IDXX logoIDXX
ZTS logoZTS
CHWY logoCHWY
IndustrySpecialty RetailMedical - Diagnostics & ResearchDrug Manufacturers - Specialty & GenericSpecialty Retail
Market Cap$752M$45.45B$36.86B$9.80B
Revenue (TTM)$5.96B$4.45B$9.51B$12.35B
Net Income (TTM)$9M$1.10B$2.64B$151M
Gross Margin38.7%62.1%70.8%29.5%
Operating Margin2.0%31.6%37.9%1.3%
Forward P/E18.8x39.5x12.4x27.0x
Total Debt$1.37B$1.08B$9.49B$502M
Cash & Equiv.$257M$180M$2.31B$596M

WOOF vs IDXX vs ZTS vs CHWYLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

WOOF
IDXX
ZTS
CHWY
StockJan 21May 26Return
Petco Health and We… (WOOF)10010.6-89.4%
IDEXX Laboratories,… (IDXX)100119.5+19.5%
Zoetis Inc. (ZTS)10056.6-43.4%
Chewy, Inc. (CHWY)10023.2-76.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: WOOF vs IDXX vs ZTS vs CHWY

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IDXX and ZTS are tied at the top with 3 categories each — the right choice depends on your priorities. Zoetis Inc. is the stronger pick specifically for valuation and capital efficiency and profitability and margin quality. CHWY also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
WOOF
Petco Health and Wellness Company, Inc.
The Quality Angle

WOOF lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: consumer cyclical exposure
IDXX
IDEXX Laboratories, Inc.
The Long-Run Compounder

IDXX carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 5.6% 10Y total return vs ZTS's 107.3%
  • 10.4% revenue growth vs WOOF's -2.5%
  • +17.6% vs ZTS's -42.7%
  • 32.6% ROA vs WOOF's 0.2%, ROIC 42.5% vs 2.9%
Best for: long-term compounding
ZTS
Zoetis Inc.
The Defensive Pick

ZTS is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.

  • Lower volatility, beta 0.90, current ratio 3.03x
  • PEG 1.04 vs IDXX's 2.76
  • Beta 0.90, yield 2.3%, current ratio 3.03x
  • Lower P/E (12.4x vs 27.0x)
Best for: sleep-well-at-night and valuation efficiency
CHWY
Chewy, Inc.
The Income Pick

CHWY is the clearest fit if your priority is income & stability and growth exposure.

  • beta 0.70
  • Rev growth 6.4%, EPS growth 8.9%, 3Y rev CAGR 9.8%
  • Beta 0.70 vs IDXX's 1.35
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthIDXX logoIDXX10.4% revenue growth vs WOOF's -2.5%
ValueZTS logoZTSLower P/E (12.4x vs 27.0x)
Quality / MarginsZTS logoZTS27.8% margin vs WOOF's 0.2%
Stability / SafetyCHWY logoCHWYBeta 0.70 vs IDXX's 1.35
DividendsZTS logoZTS2.3% yield; 13-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)IDXX logoIDXX+17.6% vs ZTS's -42.7%
Efficiency (ROA)IDXX logoIDXX32.6% ROA vs WOOF's 0.2%, ROIC 42.5% vs 2.9%

WOOF vs IDXX vs ZTS vs CHWY — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

WOOFPetco Health and Wellness Company, Inc.
FY 2023
Consumables
49.0%$3.1B
Supplies And Companion Animals
35.3%$2.2B
Services And Other
15.7%$982M
IDXXIDEXX Laboratories, Inc.
FY 2025
Product
59.0%$2.5B
Service
41.0%$1.8B
ZTSZoetis Inc.
FY 2025
Horses
67.8%$6.3B
Cattle
16.1%$1.5B
Swine
5.0%$466M
Poultry
4.7%$432M
Dogs and Cats
3.3%$304M
Fish
3.1%$286M
CHWYChewy, Inc.
FY 2024
Reportable Segment
100.0%$11.9B

WOOF vs IDXX vs ZTS vs CHWY — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLIDXXLAGGINGCHWY

Income & Cash Flow (Last 12 Months)

ZTS leads this category, winning 4 of 6 comparable metrics.

CHWY is the larger business by revenue, generating $12.3B annually — 2.8x IDXX's $4.4B. ZTS is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to WOOF's 0.2%. On growth, IDXX holds the edge at +14.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricWOOF logoWOOFPetco Health and …IDXX logoIDXXIDEXX Laboratorie…ZTS logoZTSZoetis Inc.CHWY logoCHWYChewy, Inc.
RevenueTrailing 12 months$6.0B$4.4B$9.5B$12.3B
EBITDAEarnings before interest/tax$317M$1.5B$4.0B$313M
Net IncomeAfter-tax profit$9M$1.1B$2.6B$151M
Free Cash FlowCash after capex$286M$845M$2.1B$463M
Gross MarginGross profit ÷ Revenue+38.7%+62.1%+70.8%+29.5%
Operating MarginEBIT ÷ Revenue+2.0%+31.6%+37.9%+1.3%
Net MarginNet income ÷ Revenue+0.2%+24.6%+27.8%+1.2%
FCF MarginFCF ÷ Revenue+4.8%+19.0%+22.5%+3.8%
Rev. Growth (YoY)Latest quarter vs prior year-2.4%+14.3%+1.9%+8.6%
EPS Growth (YoY)Latest quarter vs prior year+81.6%+16.6%+0.7%-79.4%
ZTS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

WOOF leads this category, winning 4 of 7 comparable metrics.

At 14.5x trailing earnings, ZTS trades at a 83% valuation discount to WOOF's 86.8x P/E. Adjusting for growth (PEG ratio), ZTS offers better value at 1.21x vs IDXX's 3.06x — a lower PEG means you pay less per unit of expected earnings growth.

MetricWOOF logoWOOFPetco Health and …IDXX logoIDXXIDEXX Laboratorie…ZTS logoZTSZoetis Inc.CHWY logoCHWYChewy, Inc.
Market CapShares × price$752M$45.4B$36.9B$9.8B
Enterprise ValueMkt cap + debt − cash$1.9B$46.3B$44.0B$9.7B
Trailing P/EPrice ÷ TTM EPS86.75x43.75x14.50x25.99x
Forward P/EPrice ÷ next-FY EPS est.18.76x39.45x12.43x27.02x
PEG RatioP/E ÷ EPS growth rate3.06x1.21x
EV / EBITDAEnterprise value multiple5.89x31.60x10.78x42.76x
Price / SalesMarket cap ÷ Revenue0.13x10.56x3.89x0.83x
Price / BookPrice ÷ Book value/share0.68x28.75x11.63x38.99x
Price / FCFMarket cap ÷ FCF2.39x43.14x16.14x21.67x
WOOF leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

IDXX leads this category, winning 6 of 8 comparable metrics.

IDXX delivers a 70.9% return on equity — every $100 of shareholder capital generates $71 in annual profit, vs $1 for WOOF. IDXX carries lower financial leverage with a 0.67x debt-to-equity ratio, signaling a more conservative balance sheet compared to ZTS's 2.85x.

MetricWOOF logoWOOFPetco Health and …IDXX logoIDXXIDEXX Laboratorie…ZTS logoZTSZoetis Inc.CHWY logoCHWYChewy, Inc.
ROE (TTM)Return on equity+0.8%+70.9%+62.4%+38.8%
ROA (TTM)Return on assets+0.2%+32.6%+17.5%+4.8%
ROICReturn on invested capital+2.9%+42.5%+26.9%+28.0%
ROCEReturn on capital employed+3.0%+61.4%+29.9%+12.0%
Piotroski ScoreFundamental quality 0–97777
Debt / EquityFinancial leverage1.18x0.67x2.85x1.92x
Net DebtTotal debt minus cash$1.1B$897M$7.2B-$93M
Cash & Equiv.Liquid assets$257M$180M$2.3B$596M
Total DebtShort + long-term debt$1.4B$1.1B$9.5B$502M
Interest CoverageEBIT ÷ Interest expense0.95x35.55x11.33x35.37x
IDXX leads this category, winning 6 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

IDXX leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in IDXX five years ago would be worth $10,513 today (with dividends reinvested), compared to $1,154 for WOOF. Over the past 12 months, IDXX leads with a +17.6% total return vs ZTS's -42.7%. The 3-year compound annual growth rate (CAGR) favors IDXX at 5.6% vs WOOF's -35.4% — a key indicator of consistent wealth creation.

MetricWOOF logoWOOFPetco Health and …IDXX logoIDXXIDEXX Laboratorie…ZTS logoZTSZoetis Inc.CHWY logoCHWYChewy, Inc.
YTD ReturnYear-to-date-3.5%-14.6%-29.8%-29.4%
1-Year ReturnPast 12 months-14.1%+17.6%-42.7%-38.3%
3-Year ReturnCumulative with dividends-73.0%+17.9%-49.8%-29.2%
5-Year ReturnCumulative with dividends-88.5%+5.1%-44.4%-66.7%
10-Year ReturnCumulative with dividends-90.6%+556.2%+107.3%-32.4%
CAGR (3Y)Annualised 3-year return-35.4%+5.6%-20.5%-10.9%
IDXX leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — IDXX and CHWY each lead in 1 of 2 comparable metrics.

CHWY is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than IDXX's 1.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IDXX currently trades 74.3% from its 52-week high vs CHWY's 48.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricWOOF logoWOOFPetco Health and …IDXX logoIDXXIDEXX Laboratorie…ZTS logoZTSZoetis Inc.CHWY logoCHWYChewy, Inc.
Beta (5Y)Sensitivity to S&P 5000.92x1.35x0.90x0.70x
52-Week HighHighest price in past year$4.51$769.98$172.23$48.62
52-Week LowLowest price in past year$2.24$471.74$85.31$22.74
% of 52W HighCurrent price vs 52-week peak+61.0%+74.3%+50.7%+48.7%
RSI (14)Momentum oscillator 0–10042.552.134.941.4
Avg Volume (50D)Average daily shares traded2.6M533K3.7M7.7M
Evenly matched — IDXX and CHWY each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: WOOF as "Hold", IDXX as "Buy", ZTS as "Hold", CHWY as "Buy". Consensus price targets imply 76.3% upside for CHWY (target: $42) vs 30.5% for WOOF (target: $4). ZTS is the only dividend payer here at 2.29% yield — a key consideration for income-focused portfolios.

MetricWOOF logoWOOFPetco Health and …IDXX logoIDXXIDEXX Laboratorie…ZTS logoZTSZoetis Inc.CHWY logoCHWYChewy, Inc.
Analyst RatingConsensus buy/hold/sellHoldBuyHoldBuy
Price TargetConsensus 12-month target$3.59$773.13$143.00$41.71
# AnalystsCovering analysts25223038
Dividend YieldAnnual dividend ÷ price+2.3%
Dividend StreakConsecutive years of raises13
Dividend / ShareAnnual DPS$2.00
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.7%+8.8%+9.6%
Insufficient data to determine a leader in this category.
Key Takeaway

IDXX leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). ZTS leads in 1 (Income & Cash Flow). 1 tied.

Best OverallIDEXX Laboratories, Inc. (IDXX)Leads 2 of 6 categories
Loading custom metrics...

WOOF vs IDXX vs ZTS vs CHWY: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is WOOF or IDXX or ZTS or CHWY a better buy right now?

For growth investors, IDEXX Laboratories, Inc.

(IDXX) is the stronger pick with 10. 4% revenue growth year-over-year, versus -2. 5% for Petco Health and Wellness Company, Inc. (WOOF). Zoetis Inc. (ZTS) offers the better valuation at 14. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate IDEXX Laboratories, Inc. (IDXX) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — WOOF or IDXX or ZTS or CHWY?

On trailing P/E, Zoetis Inc.

(ZTS) is the cheapest at 14. 5x versus Petco Health and Wellness Company, Inc. at 86. 8x. On forward P/E, Zoetis Inc. is actually cheaper at 12. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Zoetis Inc. wins at 1. 04x versus IDEXX Laboratories, Inc. 's 2. 76x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — WOOF or IDXX or ZTS or CHWY?

Over the past 5 years, IDEXX Laboratories, Inc.

(IDXX) delivered a total return of +5. 1%, compared to -88. 5% for Petco Health and Wellness Company, Inc. (WOOF). Over 10 years, the gap is even starker: IDXX returned +556. 2% versus WOOF's -90. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — WOOF or IDXX or ZTS or CHWY?

By beta (market sensitivity over 5 years), Chewy, Inc.

(CHWY) is the lower-risk stock at 0. 70β versus IDEXX Laboratories, Inc. 's 1. 35β — meaning IDXX is approximately 91% more volatile than CHWY relative to the S&P 500. On balance sheet safety, IDEXX Laboratories, Inc. (IDXX) carries a lower debt/equity ratio of 67% versus 3% for Zoetis Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — WOOF or IDXX or ZTS or CHWY?

By revenue growth (latest reported year), IDEXX Laboratories, Inc.

(IDXX) is pulling ahead at 10. 4% versus -2. 5% for Petco Health and Wellness Company, Inc. (WOOF). On earnings-per-share growth, the picture is similar: Chewy, Inc. grew EPS 893. 4% year-over-year, compared to 10. 1% for Zoetis Inc.. Over a 3-year CAGR, CHWY leads at 9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — WOOF or IDXX or ZTS or CHWY?

Zoetis Inc.

(ZTS) is the more profitable company, earning 28. 2% net margin versus 0. 2% for Petco Health and Wellness Company, Inc. — meaning it keeps 28. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ZTS leads at 38. 0% versus 0. 9% for CHWY. At the gross margin level — before operating expenses — ZTS leads at 70. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is WOOF or IDXX or ZTS or CHWY more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Zoetis Inc. (ZTS) is the more undervalued stock at a PEG of 1. 04x versus IDEXX Laboratories, Inc. 's 2. 76x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Zoetis Inc. (ZTS) trades at 12. 4x forward P/E versus 39. 5x for IDEXX Laboratories, Inc. — 27. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHWY: 76. 3% to $41. 71.

08

Which pays a better dividend — WOOF or IDXX or ZTS or CHWY?

In this comparison, ZTS (2.

3% yield) pays a dividend. WOOF, IDXX, CHWY do not pay a meaningful dividend and should not be held primarily for income.

09

Is WOOF or IDXX or ZTS or CHWY better for a retirement portfolio?

For long-horizon retirement investors, Zoetis Inc.

(ZTS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 90), 2. 3% yield, +107. 3% 10Y return). Both have compounded well over 10 years (ZTS: +107. 3%, WOOF: -90. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between WOOF and IDXX and ZTS and CHWY?

These companies operate in different sectors (WOOF (Consumer Cyclical) and IDXX (Healthcare) and ZTS (Healthcare) and CHWY (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: WOOF is a small-cap quality compounder stock; IDXX is a mid-cap quality compounder stock; ZTS is a mid-cap deep-value stock; CHWY is a small-cap quality compounder stock. ZTS pays a dividend while WOOF, IDXX, CHWY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

WOOF

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 23%
Run This Screen
Stocks Like

IDXX

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 14%
Run This Screen
Stocks Like

ZTS

Dividend Mega-Cap Quality

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 16%
  • Dividend Yield > 0.9%
Run This Screen
Stocks Like

CHWY

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 17%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform WOOF and IDXX and ZTS and CHWY on the metrics below

Revenue Growth>
%
(WOOF: -2.4% · IDXX: 14.3%)
P/E Ratio<
x
(WOOF: 86.8x · IDXX: 43.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.